Teva Pharma Industries Stock Price Prediction

TEVA Stock  USD 14.06  0.37  2.56%   
The relative strength index (RSI) of Teva Pharma's the stock price is about 61. This usually implies that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Teva, making its price go up or down.

Oversold Vs Overbought

61

 
Oversold
 
Overbought
Teva Pharma Industries stock price prediction is an act of determining the future value of Teva Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Teva Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Teva Pharma and does not consider all of the tangible or intangible factors available from Teva Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Teva Pharma Industries, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Teva Pharma's stock price prediction:
Quarterly Earnings Growth
0.4
EPS Estimate Next Quarter
0.5
EPS Estimate Current Year
2.4
EPS Estimate Next Year
2.63
Wall Street Target Price
15.13
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Teva Pharma based on different types of headlines from major news networks to social media. The Teva stock price prediction module provides an analysis of price elasticity to changes in media outlook on Teva Pharma over a specific investment horizon. Using Teva Pharma hype-based prediction, you can estimate the value of Teva Pharma Industries from the perspective of Teva Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Teva Pharma using Teva Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Teva using crowd psychology based on the activity and movement of Teva Pharma's stock price.

Teva Pharma Short Interest

A significant increase or decrease in Teva Pharma's short interest from the previous month could be a good indicator of investor sentiment towards Teva. Short interest can provide insight into the potential direction of Teva Pharma stock and how bullish or bearish investors feel about the market overall. An investor who is long Teva Pharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about Teva Pharma and may potentially protect profits, hedge Teva Pharma with its derivative instruments, or be ready for some potential downside.
200 Day MA
10.1401
Short Percent
0.0179
Short Ratio
1.17
Shares Short Prior Month
18.3 M
50 Day MA
12.7894

Teva Pharma Industries Hype to Price Pattern

Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Teva Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Teva Pharma.

Teva Pharma Implied Volatility

    
  64.86  
Teva Pharma's implied volatility exposes the market's sentiment of Teva Pharma Industries stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Teva Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Teva Pharma stock will not fluctuate a lot when Teva Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Teva Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Teva Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Teva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Teva Pharma after-hype prediction price

    
  USD 14.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Teva contract

Based on the Rule 16, the options market is currently suggesting that Teva Pharma Industries will have an average daily up or down price movement of about 4.05% per day over the life of the 2024-03-28 option contract. With Teva Pharma trading at USD 14.06, that is roughly USD 0.57 . If you think that the market is fully incorporating Teva Pharma's daily price movement you should consider acquiring Teva Pharma Industries options at the current volatility level of 64.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Teva Pharma Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
11.3813.1414.90
Details
Naive
Forecast
LowNextHigh
12.8614.6216.38
Details
13 Analysts
Consensus
LowTargetHigh
9.6110.5611.72
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.540.580.61
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Teva Pharma. Your research has to be compared to or analyzed against Teva Pharma's peers to derive any actionable benefits. When done correctly, Teva Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Teva Pharma Industries.

Teva Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Teva Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Teva Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Teva Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Teva Pharma Estimiated After-Hype Price Volatility

In the context of predicting Teva Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Teva Pharma's historical news coverage. Teva Pharma's after-hype downside and upside margins for the prediction period are 12.37 and 15.89, respectively. We have considered Teva Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
14.06
14.13
After-hype Price
15.89
Upside
Teva Pharma is not too volatile at this time. Analysis and calculation of next after-hype price of Teva Pharma Industries is based on 3 months time horizon.

Teva Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Teva Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teva Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Teva Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.55 
1.76
  0.07 
  0.80 
11 Events / Month
6 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
14.06
14.13
0.50 
1,354  
Notes

Teva Pharma Hype Timeline

Teva Pharma Industries is at this time traded for 14.06. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of 0.8. Teva is anticipated to increase in value after the next headline, with the price projected to jump to 14.13 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.5%, whereas the daily expected return is at this time at 0.55%. The volatility of related hype on Teva Pharma is about 120.84%, with the expected price after the next announcement by competition of 14.86. The company reported the previous year's revenue of 15.85 B. Net Loss for the year was (615 M) with profit before overhead, payroll, taxes, and interest of 6.97 B. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days.
Check out Teva Pharma Basic Forecasting Models to cross-verify your projections.

Teva Pharma Related Hype Analysis

Having access to credible news sources related to Teva Pharma's direct competition is more important than ever and may enhance your ability to predict Teva Pharma's future price movements. Getting to know how Teva Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Teva Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies 3.49 11 per month 1.43 (0.02) 2.27 (2.26) 5.92 
MBIOMustang Bio(0.04)3 per month 0.00 (0.12) 5.30 (8.49) 20.58 
MBRXMoleculin Biotech 5.79 9 per month 0.00 (0.11) 11.19 (11.18) 34.21 
CLVRWClever Leaves Holdings 0.01 2 per month 7.03  0.17  29.03 (12.50) 74.95 
MCRBSeres Therapeutics 0.01 10 per month 0.00 (0.09) 8.70 (8.33) 29.80 
MDGLMadrigal Pharmaceuticals 4.05 8 per month 4.45  0.04  8.89 (7.09) 24.70 
EQEquillium(0.15)10 per month 5.96  0.20  20.33 (10.80) 70.42 
KAKineta Inc(0.02)7 per month 0.00 (0.26) 8.68 (9.84) 72.56 
ME23Andme Holding Co(0.03)11 per month 0.00 (0.11) 10.61 (10.00) 34.64 

Teva Pharma Additional Predictive Modules

Most predictive techniques to examine Teva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Teva using various technical indicators. When you analyze Teva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Teva Pharma Predictive Indicators

The successful prediction of Teva Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Teva Pharma Industries, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharma based on analysis of Teva Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Teva Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Teva Pharma's related companies.
 2023 2024 (projected)
Dividend Yield0.0043770.004158
Price To Sales Ratio0.740.7

Story Coverage note for Teva Pharma

The number of cover stories for Teva Pharma depends on current market conditions and Teva Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Teva Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Teva Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Teva Pharma Short Properties

Teva Pharma's future price predictability will typically decrease when Teva Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Teva Pharma Industries often depends not only on the future outlook of the potential Teva Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.1 B
Cash And Short Term Investments3.2 B
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:
Check out Teva Pharma Basic Forecasting Models to cross-verify your projections.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Teva Stock analysis

When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Teva Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.4
Earnings Share
(0.50)
Revenue Per Share
14.161
Quarterly Revenue Growth
0.148
Return On Assets
0.0454
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.